Evidence map›Paper›PMID 40200560›Full record

ArticleNutrition and cancer2025

The Association between Tea Consumption and Bladder Cancer Risk Based on the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Consortium.

Yan-Xi Zhang, Richard Albers, Ya-Ting Chen, Gunnar Steineck, Eliane Kellen, Kenneth C Johnson, Chih-Ming Lu, Hermann Pohlabeln, Carlo La Vecchia, Stefano Porru and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrition and cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yan-Xi ZhangKey Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Richard AlbersDepartment of Epidemiology, CAPHRI Care and Public Health Research Institute, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Ya-Ting ChenKey Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Gunnar SteineckDepartment of Oncology and Pathology, Division of Clinical Cancer Epidemiology, Karolinska Hospital, Stockholm, Sweden.
Eliane KellenLeuven University Centre for Cancer Prevention (LUCK), Leuven, Belgium.
Kenneth C JohnsonDepartment of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada.
Chih-Ming LuDepartment of Urology, Buddhist Dalin Tzu Chi General Hospital, Dalin Township, Chiayi County, Taiwan.
Hermann PohlabelnLeibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Carlo La VecchiaDepartment of Clinical Medicine and Community Health, University of Milan, Milan, Italy.
Stefano PorruDepartment of Diagnostics and Public Health, Section of Occupational Health, University of Verona, Verona, Italy.
Angela CartaUniversity Research Center 'Integrated Models for Prevention and Protection in Environmental and Occupational Health' MISTRAL, University of Verona, Milano Bicocca and Brescia, Italy.
Jerry PoleselUnit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Cristina BosettiDepartment of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Xuejuan JiangDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
Li TangDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
James MarshallDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Margaret R KaragasDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Zuo-Feng ZhangDepartments of Epidemiology, UCLA Center for Environmental Genomics, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Jack A TaylorEpidemiology Branch, and Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, NC, USA.
Maurice P A ZeegersDepartment of Epidemiology, CAPHRI Care and Public Health Research Institute, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Anke WesseliusDepartment of Epidemiology, CAPHRI Care and Public Health Research Institute, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Evan Yi-Wen YuKey Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing, China.ORCID 0000-0001-7825-5087

Funding

GENETIC SUSCEPTIBILITY AND THE ENVIRONMENT IN CANCER RISKZ01ES049033 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI TAYLOR, JACK A · 1997 to 2008
$1.4M
Intramural NIH HHS Z01 ES049033
6 · The paper itself

Abstract

objectivesEvidence regarding the association between tea consumption and bladder cancer (BC) risk is inconsistent. This study aimed to increase our knowledge of the association by using international data from the Bladder Cancer Epidemiology and Nutritional Determinants Consortium.

methodsIndividual data on 2,347 cases and 6,871 controls from 15 case-control studies with information on black, green, herbal, or general tea was pooled. The association was estimated using multilevel multivariable logistic regression analysis adjusted for multiple (non-)dietary factors.

resultsAssociation between tea consumption and BC risk was observed (odds ratio, OR = 0.72, 95% confidence interval, 95% CI = 0.65-0.80) compared to non-tea drinkers. Stratified analyses based on gender and smoking status yielded similar results. Stratified analysis showed no significant association between black or green tea consumption and BC risk across models, while herbal tea consumption was linked to a reduced BC risk (OR = 0.59, 95% CI = 0.36-0.96). As daily tea consumption increased within a suitable range (<5.67 cups/day), BC risk decreased.

conclusions

Indexed as

TeaUrinary Bladder NeoplasmsAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedRisk FactorsTea

Identifiers

PMID40200560
PMCPMC12433241

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.